title: A pharmacoeconomic evaluation of amlodipine usage in patients undergoing PTCA in the US using results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES).
authors: Department of Cardiology, Rikshospitalet, University of Oslo, Oslo, Norway.
authors: E
authors: E
authors: Thaulow
authors: B
authors: B
authors: Jorgensen
authors: J J
authors: JJ
authors: Doyle
authors: R
authors: R
authors: Casciano
authors: J
authors: J
authors: Casciano
authors: S
authors: S
authors: Arikian
authors: R
authors: R
authors: Kim
authors: R
authors: R
authors: Arocho
authors: Z
authors: Z
authors: Kopp
mesh_terms: D017311:Amlodipine / Q000191:economics* / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000191:economics; D002121:Calcium Channel Blockers / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs / Q000706:statistics & numerical data*; D006083:Graft Occlusion, Vascular / Q000601:surgery*; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000191:economics*; D010919:Placebos; D014481:United States
chemical_list: D002121:Calcium Channel Blockers; D010919:Placebos; D017311:Amlodipine